Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Role of Nebulised Mucolytic Therapy During Lower Respiratory Tract Infections Post Lung Transplantation.

NCT01952470 is registered in ClinicalTrials.gov with The Alfred as lead sponsor.

NCT NCT01952470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01952470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Role of Nebulised Mucolytic Therapy During Lower Respiratory Tract Infections Post Lung Transplantation.
Lead sponsor
The Alfred
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
August 23, 2017
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower respiratory tract infection, lung transplant infection